南京化纖(600889.SH):控股子公司更名為南京金羚生物基纖維有限公司及變更經營範圍
格隆匯3月27日丨南京化纖(600889.SH)公佈,2020年3月27日,南京化纖股份有限公司接到控股子公司南京法伯耳紡織有限公司通知,因經營發展需要,其完成了公司名稱及經營範圍的工商變更登記手續,取得了南京市市場監督管理局換髮的《營業執照》。
變更後名稱為南京金羚生物基纖維有限公司,變更後經營範圍為:天然水收集與分配;貨物進出口;技術進出口;進出口代理(依法須經批准的項目,經相關部門批准後方可開展經營活動,具體經營項目以審批結果為準)。一般項目:生物基材料製造;生物基材料銷售;生物基材料技術研發;物業管理;機械設備租賃(除依法須經批准的項目外,憑營業執照依法自主開展經營活動)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.